August 22, 2025

New CT Score Tracks Pneumonia Stage Progression

Researchers validate a visual CT scoring system designed to improve classification of pneumonia-related lung changes in clinical and research settings.

Conexiant

August 22, 2025

Nemolizumab Study Tracks 68 Weeks of Relief

A long-term clinical study finds that the biologic therapy nemolizumab, when used with topical corticosteroids, continues to improve itch, sleep, and skin symptoms in prurigo nodularis patients over 68 weeks.

Conexiant

August 22, 2025

Higher Rates of Oral Pathologies Found in Diabetes

Review of hospital records revealed increased risks of malignant tumors, periodontal disease, apical periodontitis, and periapical cysts among patients with diabetes compared with those without.

Conexiant

August 22, 2025

Evidence of Potential Cure With Single CAR T-Cell Infusion for Some Patients With Multiple Myeloma

In long-term results from the CARTITUDE-1 trial, investigators had found that the autologous cellular immunotherapy ciltacabtagene autoleucel was potentially curative for one-third of patients with he...

The ASCO Post

August 22, 2025

Seven-Factor Tool Improves Sepsis Death Prediction

An admission-based model predicted 28-day mortality more accurately than SOFA and APACHE II, offering a potential tool for early risk stratification in ICU patients with sepsis secondary to pneumonia.

Conexiant

August 22, 2025

Linear Hyperpigmentation After Chemotherapy: What's Your Diagnosis?

A 15-year-old girl developed distinctive, painless, whip-like streaks across her trunk and back after receiving combination chemotherapy for ovarian yolk sac tumor. What’s your diagnosis?

Conexiant

August 22, 2025

'Clear' E-Cigarettes Can Raise Blood Pressure and Heart Rate, Study

Marketed as unflavored, “clear” e-cigarettes contain synthetic cooling agents, menthol, and other flavorants, and were associated with greater cardiovascular effects than flavored e-cigs and nonuse.

Conexiant

August 22, 2025

John C. Byrd, MD, FASCO, Named UPMC Hillman Cancer Center Director

An internationally lauded researcher and clinical specialist in hematologic malignancies has been appointed Director of UPMC Hillman Cancer Center, effective November 2025.

The ASCO Post

August 22, 2025

OHSU Knight Cancer Institute Receives $2 Billion Commitment From Phil and Penny Knight

The ASCO Post